Theranostic nanoparticles for future personalized medicine

Ju Hee Ryu, Sangmin Lee, Sohee Son, Sun Hwa Kim, James F. Leary, Kuiwon Choi, Ick Chan Kwon

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

The concept of personalized medicine has recently emerged as a promising way to address unmet medical needs. Due to the limitations of standard diagnostic and therapeutic strategies, the disease treatment is moving towards tailored treatment for individual patients, considering the inter-individual variability in therapeutic response. Theranostics, which involves the combination of therapy and diagnostic imaging into a single system, may fulfill the promise of personalized medicine. By integrating molecular imaging functionalities into therapy, theranostic approach could be advantageous in therapy selection, treatment planning, objective response monitoring and follow-up therapy planning based on the specific molecular characteristics of a disease. Although the field of therapy and imaging of its response have been independently developed thus far, developing imaging strategies can be fully exploited to revolutionize the theranostic systems in combination with the therapy modality. In this review, we describe the recent advances in molecular imaging technologies that have been specifically developed to evaluate the therapeutic efficacy for theranostic purposes.

Original languageEnglish
Pages (from-to)477-484
Number of pages8
JournalJournal of Controlled Release
Volume190
DOIs
Publication statusPublished - 2014 Sep 28

Fingerprint

Precision Medicine
Nanoparticles
Therapeutics
Molecular Imaging
Theranostic Nanomedicine
Diagnostic Imaging

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Ryu, J. H., Lee, S., Son, S., Kim, S. H., Leary, J. F., Choi, K., & Kwon, I. C. (2014). Theranostic nanoparticles for future personalized medicine. Journal of Controlled Release, 190, 477-484. https://doi.org/10.1016/j.jconrel.2014.04.027

Theranostic nanoparticles for future personalized medicine. / Ryu, Ju Hee; Lee, Sangmin; Son, Sohee; Kim, Sun Hwa; Leary, James F.; Choi, Kuiwon; Kwon, Ick Chan.

In: Journal of Controlled Release, Vol. 190, 28.09.2014, p. 477-484.

Research output: Contribution to journalArticle

Ryu, JH, Lee, S, Son, S, Kim, SH, Leary, JF, Choi, K & Kwon, IC 2014, 'Theranostic nanoparticles for future personalized medicine', Journal of Controlled Release, vol. 190, pp. 477-484. https://doi.org/10.1016/j.jconrel.2014.04.027
Ryu, Ju Hee ; Lee, Sangmin ; Son, Sohee ; Kim, Sun Hwa ; Leary, James F. ; Choi, Kuiwon ; Kwon, Ick Chan. / Theranostic nanoparticles for future personalized medicine. In: Journal of Controlled Release. 2014 ; Vol. 190. pp. 477-484.
@article{9b1cadc3945d41a599034febb7dd2d71,
title = "Theranostic nanoparticles for future personalized medicine",
abstract = "The concept of personalized medicine has recently emerged as a promising way to address unmet medical needs. Due to the limitations of standard diagnostic and therapeutic strategies, the disease treatment is moving towards tailored treatment for individual patients, considering the inter-individual variability in therapeutic response. Theranostics, which involves the combination of therapy and diagnostic imaging into a single system, may fulfill the promise of personalized medicine. By integrating molecular imaging functionalities into therapy, theranostic approach could be advantageous in therapy selection, treatment planning, objective response monitoring and follow-up therapy planning based on the specific molecular characteristics of a disease. Although the field of therapy and imaging of its response have been independently developed thus far, developing imaging strategies can be fully exploited to revolutionize the theranostic systems in combination with the therapy modality. In this review, we describe the recent advances in molecular imaging technologies that have been specifically developed to evaluate the therapeutic efficacy for theranostic purposes.",
keywords = "Molecular imaging, Monitoring response, Personalized medicine, Theranostics",
author = "Ryu, {Ju Hee} and Sangmin Lee and Sohee Son and Kim, {Sun Hwa} and Leary, {James F.} and Kuiwon Choi and Kwon, {Ick Chan}",
year = "2014",
month = "9",
day = "28",
doi = "10.1016/j.jconrel.2014.04.027",
language = "English",
volume = "190",
pages = "477--484",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",

}

TY - JOUR

T1 - Theranostic nanoparticles for future personalized medicine

AU - Ryu, Ju Hee

AU - Lee, Sangmin

AU - Son, Sohee

AU - Kim, Sun Hwa

AU - Leary, James F.

AU - Choi, Kuiwon

AU - Kwon, Ick Chan

PY - 2014/9/28

Y1 - 2014/9/28

N2 - The concept of personalized medicine has recently emerged as a promising way to address unmet medical needs. Due to the limitations of standard diagnostic and therapeutic strategies, the disease treatment is moving towards tailored treatment for individual patients, considering the inter-individual variability in therapeutic response. Theranostics, which involves the combination of therapy and diagnostic imaging into a single system, may fulfill the promise of personalized medicine. By integrating molecular imaging functionalities into therapy, theranostic approach could be advantageous in therapy selection, treatment planning, objective response monitoring and follow-up therapy planning based on the specific molecular characteristics of a disease. Although the field of therapy and imaging of its response have been independently developed thus far, developing imaging strategies can be fully exploited to revolutionize the theranostic systems in combination with the therapy modality. In this review, we describe the recent advances in molecular imaging technologies that have been specifically developed to evaluate the therapeutic efficacy for theranostic purposes.

AB - The concept of personalized medicine has recently emerged as a promising way to address unmet medical needs. Due to the limitations of standard diagnostic and therapeutic strategies, the disease treatment is moving towards tailored treatment for individual patients, considering the inter-individual variability in therapeutic response. Theranostics, which involves the combination of therapy and diagnostic imaging into a single system, may fulfill the promise of personalized medicine. By integrating molecular imaging functionalities into therapy, theranostic approach could be advantageous in therapy selection, treatment planning, objective response monitoring and follow-up therapy planning based on the specific molecular characteristics of a disease. Although the field of therapy and imaging of its response have been independently developed thus far, developing imaging strategies can be fully exploited to revolutionize the theranostic systems in combination with the therapy modality. In this review, we describe the recent advances in molecular imaging technologies that have been specifically developed to evaluate the therapeutic efficacy for theranostic purposes.

KW - Molecular imaging

KW - Monitoring response

KW - Personalized medicine

KW - Theranostics

UR - http://www.scopus.com/inward/record.url?scp=84906787631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906787631&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2014.04.027

DO - 10.1016/j.jconrel.2014.04.027

M3 - Article

C2 - 24780269

AN - SCOPUS:84906787631

VL - 190

SP - 477

EP - 484

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

ER -